You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

posterior uveitis

Showing 1 - 25 of 2,731
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate Trial in Waltham (Ixekizumab Prefilled Syringe)

Recruiting
  • Uveitis, Posterior
  • +3 more
  • Ixekizumab Prefilled Syringe
  • Waltham, Massachusetts
    Massachusetts Eye Research and Surgery Institution
Oct 11, 2023

Non-infectious Uveitis Trial (care strategy)

Not yet recruiting
  • Non-infectious Uveitis
  • care strategy
  • (no location specified)
Jun 26, 2023

Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)

Active, not recruiting
  • Uveitis
  • +2 more
  • Sham Injector
  • FAI Insert
  • Waltham, Massachusetts
    EyePoint Study Site
Dec 20, 2022

Uveitis Posterior Non-Infectious, Uveitis, Intermediate, Noninfectious Panuveitis Trial in Waltham, Erie (ESK-001)

Recruiting
  • Uveitis Posterior Non-Infectious
  • +2 more
  • Waltham, Massachusetts
  • +1 more
Jul 18, 2023

Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial (Ozurdex 0.7mg Ophthalmic Implant, Prednisone)

Recruiting
  • Uveitis, Posterior
  • +2 more
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute - Vision Research Centre
Dec 14, 2022

Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)

Not yet recruiting
  • Uveitis
  • +3 more
  • Yutiq 0.18 MG Drug Implant
  • Sham Injection
  • Plano, Texas
    Texas Retina Associates
Aug 3, 2022

Birdshot Chorioretinopathy : Prospective Follow-up and

Recruiting
  • Birdshot Chorioretinopathy
  • Posterior Uveitis
  • Observational study
  • Paris, Île-de-France, France
    Ophtalmopôle, Hôpital Cochin
Dec 9, 2021

Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)

Recruiting
  • Uveitis, Posterior
  • Fluocinolone Acetonide Intravitreal Implant 0.18 mg
  • Phoenix, Arizona
  • +16 more
Aug 18, 2022

Uveitis Trial (adalimumab)

Completed
Has Results
  • Uveitis
  • (no location specified)
Jul 8, 2021

Uveitis Trial in United States (Izokibep, Placebo)

Recruiting
  • Uveitis
  • Phoenix, Arizona
  • +20 more
Jan 11, 2023

Non-infectious Intermediate Posterior- or Pan-uveitis Trial in China (Adalimumab)

Recruiting
  • Non-infectious Intermediate Posterior- or Pan-uveitis
  • Beijing, Beijing, China
  • +7 more
Dec 6, 2022

Uveitis Trial (Adalimumab, Prednisone, Placebo)

Completed
Has Results
  • Uveitis
  • (no location specified)
Jul 2, 2021

Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)

Active, not recruiting
  • Uveitis
  • Los Angeles, California
  • +3 more
Jul 18, 2022

Uveitis, Cataract, Inflammation Trial in Mölndal (Hydrophobic IOL: Vivinex (HOYA), Hydrophilic IOL: INCISE (Bausch+Lomb))

Active, not recruiting
  • Uveitis
  • +3 more
  • Hydrophobic IOL: Vivinex (HOYA)
  • Hydrophilic IOL: INCISE (Bausch+Lomb)
  • Mölndal, Sweden
    Vastra Gotaland Region, Sahlgrenska University Hospital, Departm
Apr 26, 2022

Uveitis Trial (Adalimumab, Prednisone, Placebo)

Completed
Has Results
  • Uveitis
  • Adalimumab
  • +2 more
  • (no location specified)
Jul 2, 2021

Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Palo Alto (Intravitreal injection 440mcg, Intravitreal injection of

Recruiting
  • Uveitis
  • +3 more
  • Intravitreal injection 440mcg
  • Intravitreal injection of sirolimus 880mcg
  • Palo Alto, California
    Stanford University
May 5, 2021

Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial in United States (Acthar Gel)

Terminated
Has Results
  • Uveitis, Posterior
  • +2 more
  • Acthar Gel
  • Clearwater, Florida
  • +7 more
Jul 12, 2021

Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Chicago, Omaha, Cleveland (triamcinolone acetonide (Triesence®))

Completed
Has Results
  • Uveitis
  • +4 more
  • triamcinolone acetonide (Triesence®)
  • Chicago, Illinois
  • +2 more
Feb 17, 2021

Non-infectious Uveitis Trial in France, United Kingdom (pEYS606)

Completed
  • Non-infectious Uveitis
  • pEYS606
  • Grenoble, France
  • +3 more
Mar 9, 2022

Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in United States (4 mg CLS-TA Suprachoriodal Injection)

Completed
Has Results
  • Uveitis
  • +4 more
  • 4 mg CLS-TA Suprachoriodal Injection
  • Phoenix, Arizona
  • +9 more
Jun 18, 2021

Uveitis, Posterior Uveitis, Panuveitis Trial in United States (AEB071)

Completed
  • Uveitis
  • +2 more
  • Los Angeles, California
  • +12 more
Dec 15, 2020

Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Panuveitis Trial in United Kingdom, United

Completed
Has Results
  • Non-infectious Intermediate Uveitis
  • +2 more
  • Golden, Colorado
  • +7 more
Dec 9, 2020

Non-infectious Uveitis Who Participated in CLS1001-301

Completed
Has Results
  • Uveitis
  • +4 more
  • 4 mg CLS-TA Suprachoriodal Injection
  • Sham procedure
  • Phoenix, Arizona
  • +15 more
May 13, 2021

Uveitis, Macular Edema, Uveitis, Posterior Trial in United States (4 mg CLS-TA, 0.8 mg CLS-TA)

Completed
Has Results
  • Uveitis
  • +5 more
  • 4 mg CLS-TA
  • 0.8 mg CLS-TA
  • Miami, Florida
  • +10 more
Jan 18, 2021

Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)

Completed
Has Results
  • Posterior Uveitis
  • +2 more
  • Sham Injection
  • FAI Insert
  • Hyderabad, Andhra Pradesh, India
  • +14 more
Jul 10, 2020